|
|
|
|
Join the Experts To Discover a New Treatment Option for Metastatic NSCLC
Register to participate in a live broadcast featuring a live Q&A with Dr. Bernicker and Dr. Zhu, who will discuss new direction in the treatment of Metastatic NSCLC.
|
|
In this iPub®, Dr. Bernicker and Dr. Zhu will: |
|
|
|
|
Explore clinical trial data for a new treatment option
|
|
|
|
|
|
|
|
|
Review safety information for a new therapeutic option
|
|
|
|
|
|
|
|
Present a hypothetical patient case from identification to management |
|
|
|
|
|
Eric H. Bernicker, MD
Associate Professor of Clinical Medicine,
Weill Cornell Medical College
Houston Methodist Hospital Cancer Center
|
|
|
Viola Zhu, MD, PhD
Associate Clinical Professor of Medicine
|
|
|
|
|
© 2020 Blueprint Medicines Corporation.
08/2020 USBP-DA-20-006.1
|
|
|
|
|
|
|
|
OncLive® – an MJH Life Sciences™ brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive, Suite 100
Cranbury, NJ 08512
Preferences | Unsubscribe
|
|
|
